|
1
|
Savage DC: Microbial ecology of the
gastrointestinal tract. Annu Rev Microbiol. 31:107–133. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mitsuoka T and Hayakawa K: The fecal flora
in man. I. Composition of the fecal flora of various age groups.
Zentralbl Bakteriol Orig A. 223:333–342. 1973.In German. PubMed/NCBI
|
|
3
|
Zoetendal EG, Akkermans AD and De Vos WM:
Temperature gradient gel electrophoresis analysis of 16S rRNA from
human fecal samples reveals stable and host-specific communities of
active bacteria. Appl Environ Microbiol. 64:3854–3859.
1998.PubMed/NCBI
|
|
4
|
Rajilić-Stojanović M, Heilig HG, Tims S,
Zoetendal EG and de Vos WM: Long-term monitoring of the human
intestinal microbiota composition. Environ Microbiol. 15:1146–1159.
2013. View Article : Google Scholar
|
|
5
|
Frank DN, St Amand AL, Feldman RA,
Boedeker EC, Harpaz N and Pace NR: Molecular-phylogenetic
characterization of microbial community imbalances in human
inflammatory bowel diseases. Proc Natl Acad Sci USA.
104:13780–13785. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martinez C, Antolin M, Santos J, Torrejon
A, Casellas F, Borruel N, Guarner F and Malagelada JR: Unstable
composition of the fecal microbiota in ulcerative colitis during
clinical remission. Am J Gastroenterol. 103:643–648. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgan XC, Tickle TL, Sokol H, Gevers D,
Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, et
al: Dysfunction of the intestinal microbiome in inflammatory bowel
disease and treatment. Genome Biol. 13:R792012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini
V, Mardis ER and Gordon JI: An obesity-associated gut microbiome
with increased capacity for energy harvest. Nature. 444:1027–1031.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duncan SH, Lobley GE, Holtrop G, Ince J,
Johnstone AM, Louis P and Flint HJ: Human colonic microbiota
associated with diet, obesity and weight loss. Int J Obes.
32:1720–1724. 2008. View Article : Google Scholar
|
|
10
|
Schwiertz A, Taras D, Schäfer K, Beijer S,
Bos NA, Donus C and Hardt PD: Microbiota and SCFA in lean and
overweight healthy subjects. Obesity (Silver Spring). 18:190–195.
2010. View Article : Google Scholar
|
|
11
|
Irrazábal T, Belcheva A, Girardin SE,
Martin A and Philpott DJ: The multifaceted role of the intestinal
microbiota in colon cancer. Mol Cell. 54:309–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schwabe RF and Jobin C: The microbiome and
cancer. Nat Rev Cancer. 13:800–812. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ernst M, Najdovska M, Grail D,
Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS,
Hughes NR, et al: STAT3 and STAT1 mediate IL-11-dependent and
inflammation-associated gastric tumorigenesis in gp130 receptor
mutant mice. J Clin Invest. 118:1727–1738. 2008.PubMed/NCBI
|
|
14
|
Wu S, Rhee KJ, Albesiano E, Rabizadeh S,
Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al: A
human colonic commensal promotes colon tumorigenesis via activation
of T helper type 17 T cell responses. Nat Med. 15:1016–1022. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Winter SE, Lopez CA and Bäumler AJ: The
dynamics of gut-associated microbial communities during
inflammation. EMBO Rep. 14:319–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuper H, Adami HO and Trichopoulos D:
Infections as a major preventable cause of human cancer. J Intern
Med. 248:171–183. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mantovani A, Garlanda C and Allavena P:
Molecular pathways and targets in cancer-related inflammation. Ann
Med. 42:161–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lundberg JO, Weitzberg E, Cole JA and
Benjamin N: Nitrate, bacteria and human health. Nat Rev Microbiol.
2:593–602. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Belcheva A, Green B, Weiss A, Streutker C
and Martin A: Elevated incidence of polyp formation in
APC(Min/+)Msh2−/− mice is independent of
nitric oxide-induced DNA mutations. PLoS One. 8:e652042013.
View Article : Google Scholar
|
|
20
|
Cooke MS, Evans MD, Dizdaroglu M and Lunec
J: Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB
J. 17:1195–1214. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Evans MD, Dizdaroglu M and Cooke MS:
Oxidative DNA damage and disease: Induction, repair and
significance. Mutat Res. 567:1–61. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Christl SU, Scheppach W and Kasper H:
Hydrogen metabolism in the large intestine - physiology and
clinical implications. Z Gastroenterol. 33:408–413. 1995.In German.
PubMed/NCBI
|
|
23
|
Deplancke B, Finster K, Graham WV, Collier
CT, Thurmond JE and Gaskins HR: Gastrointestinal and microbial
responses to sulfate-supplemented drinking water in mice. Exp Biol
Med (Maywood). 228:424–433. 2003.
|
|
24
|
Hughes R, Cross AJ, Pollock JR and Bingham
S: Dose-dependent effect of dietary meat on endogenous colonic
N-nitrosation. Carcinogenesis. 22:199–202. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Norat T and Riboli E: Meat consumption and
colorectal cancer: A review of epidemiologic evidence. Nutr Rev.
59:37–47. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hague A, Manning AM, Hanlon KA, Huschtscha
LI, Hart D and Paraskeva C: Sodium butyrate induces apoptosis in
human colonic tumour cell lines in a p53-independent pathway:
Implications for the possible role of dietary fibre in the
prevention of large-bowel cancer. Int J Cancer. 55:498–505. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heerdt BG, Houston MA and Augenlicht LH:
Potentiation by specific short-chain fatty acids of differentiation
and apoptosis in human colonic carcinoma cell lines. Cancer Res.
54:3288–3293. 1994.PubMed/NCBI
|
|
28
|
Nagashima K, Mochizuki J, Hisada T, Suzuki
S and Shimomura K: Phylogenetic analysis of 16S ribosomal RNA gene
sequences from human fecal microbiota and improved utility of
terminal restriction fragment length polymorphism profiling. Biosci
Microflora. 25:99–107. 2006. View Article : Google Scholar
|
|
29
|
Nagashima K, Hisada T, Sato M and
Mochizuki J: Application of new primer-enzyme combinations to
terminal restriction fragment length polymorphism profiling of
bacterial populations in human feces. Appl Environ Microbiol.
69:1251–1262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi S, Tomita J, Nishioka K, Hisada
T and Nishijima M: Development of a prokaryotic universal primer
for simultaneous analysis of Bacteria and Archaea using
next-generation sequencing. PLoS One. 9:e1055922014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Muyzer G, de Waal EC and Uitterlinden AG:
Profiling of complex microbial populations by denaturing gradient
gel electrophoresis analysis of polymerase chain reaction-amplified
genes coding for 16S rRNA. Appl Environ Microbiol. 59:695–700.
1993.PubMed/NCBI
|
|
32
|
Caporaso JG, Lauber CL, Walters WA,
Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N and Knight R:
Global patterns of 16S rRNA diversity at a depth of millions of
sequences per sample. Proc Natl Acad Sci USA. 108(Suppl 1):
4516–4522. 2011. View Article : Google Scholar :
|
|
33
|
Castellarin M, Warren RL, Freeman JD,
Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P,
Allen-Vercoe E, Moore RA, et al: Fusobacterium nucleatum infection
is prevalent in human colorectal carcinoma. Genome Res. 22:299–306.
2012. View Article : Google Scholar :
|
|
34
|
Kostic AD, Gevers D, Pedamallu CS, Michaud
M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et
al: Genomic analysis identifies association of Fusobacterium with
colorectal carcinoma. Genome Res. 22:292–298. 2012. View Article : Google Scholar :
|
|
35
|
Kostic AD, Chun E, Robertson L, Glickman
JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold
GL, et al: Fusobacterium nucleatum potentiates intestinal
tumorigenesis and modulates the tumor-immune microenvironment. Cell
Host Microbe. 14:207–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rubinstein MR, Wang X, Liu W, Hao Y, Cai G
and Han YW: Fusobacterium nucleatum promotes colorectal
carcinogenesis by modulating E-cadherin/β-catenin signaling via its
FadA adhesin. Cell Host Microbe. 14:195–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Matthies A, Blaut M and Braune A:
Isolation of a human intestinal bacterium capable of daidzein and
genistein conversion. Appl Environ Microbiol. 75:1740–1744. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Setchell KD and Clerici C: Equol: History,
chemistry, and formation. J Nutr. 140:1355S–1362S. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Watanabe S, Yamaguchi M, Sobue T,
Takahashi T, Miura T, Arai Y, Mazur W, Wähälä K and Adlercreutz H:
Pharmacokinetics of soybean isoflavones in plasma, urine and feces
of men after ingestion of 60 g baked soybean powder (kinako). J
Nutr. 128:1710–1715. 1998.PubMed/NCBI
|
|
40
|
Setchell KD and Cole SJ: Method of
defining equol-producer status and its frequency among vegetarians.
J Nutr. 136:2188–2193. 2006.PubMed/NCBI
|
|
41
|
Setchell KD, Zhao X, Shoaf SE and Ragland
K: The pharmacokinetics of S-(−)equol administered as SE5-OH
tablets to healthy postmenopausal women. J Nutr. 139:2037–2043.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song KB, Atkinson C, Frankenfeld CL,
Jokela T, Wähälä K, Thomas WK and Lampe JW: Prevalence of
daidzein-metabolizing phenotypes differs between Caucasian and
Korean American women and girls. J Nutr. 136:1347–1351.
2006.PubMed/NCBI
|
|
43
|
Setchell KD: Phytoestrogens: The
biochemistry, physiology, and implications for human health of soy
isoflavones. Am J Clin Nutr. 68(Suppl 6): 1333S–1346S.
1998.PubMed/NCBI
|
|
44
|
Cai Y, Guo K, Chen C, Wang P, Zhang B,
Zhou Q, Mei F and Su Y: Soya isoflavone consumption in relation to
carotid intimamedia thickness in Chinese equol excretors aged 40–65
years. Br J Nutr. 108:1698–1704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lund TD, Munson DJ, Haldy ME, Setchell KD,
Lephart ED and Handa RJ: Equol is a novel anti-androgen that
inhibits prostate growth and hormone feedback. Biol Reprod.
70:1188–1195. 2004. View Article : Google Scholar
|
|
46
|
Brown NM, Belles CA, Lindley SL,
Zimmer-Nechemias L, Witte DP, Kim MO and Setchell KD: Mammary gland
differentiation by early life exposure to enantiomers of the soy
isoflavone metabolite equol. Food Chem Toxicol. 48:3042–3050. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Uematsu H, Sato N, Hossain MZ, Ikeda T and
Hoshino E: Degradation of arginine and other amino acids by
buty-rate-producing asaccharolytic anaerobic Gram-positive rods in
periodontal pockets. Arch Oral Biol. 48:423–429. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Barcenilla A, Pryde SE, Martin JC, Duncan
SH, Stewart CS, Henderson C and Flint HJ: Phylogenetic
relationships of butyrate-producing bacteria from the human gut.
Appl Environ Microbiol. 66:1654–1661. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wong JM, de Souza R, Kendall CW, Emam A
and Jenkins DJ: Colonic health: Fermentation and short chain fatty
acids. J Clin Gastroenterol. 40:235–243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dronamraju SS, Coxhead JM, Kelly SB and
Mathers JC: Differential antineoplastic effects of butyrate in
cells with and without a functioning DNA mismatch repair. Nutr
Cancer. 62:105–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ooi CC, Good NM, Williams DB, Lewanowitsch
T, Cosgrove LJ, Lockett TJ and Head RJ: Efficacy of butyrate
analogues in HT-29 cancer cells. Clin Exp Pharmacol Physiol.
37:482–489. 2010. View Article : Google Scholar
|
|
52
|
Roy MJ, Dionne S, Marx G, Qureshi I, Sarma
D, Levy E and Seidman EG: In vitro studies on the inhibition of
colon cancer by butyrate and carnitine. Nutrition. 25:1193–1201.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Freier TA, Beitz DC, Li L and Hartman PA:
Characterization of Eubacterium coprostanoligenes sp nov, a
cholesterol-reducing anaerobe. Int J Syst Bacteriol. 44:137–142.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Stadler J, Stern HS, Yeung KS, McGuire V,
Furrer R, Marcon N and Bruce WR: Effect of high fat consumption on
cell proliferation activity of colorectal mucosa and on soluble
faecal bile acids. Gut. 29:1326–1331. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ou J, Carbonero F, Zoetendal EG, DeLany
JP, Wang M, Newton K, Gaskins HR and O'Keefe SJ: Diet, microbiota,
and microbial metabolites in colon cancer risk in rural Africans
and African Americans. Am J Clin Nutr. 98:111–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Toprak NU, Yagci A, Gulluoglu BM, Akin ML,
Demirkalem P, Celenk T and Soyletir G: A possible role of
Bacteroides fragilis enterotoxin in the aetiology of colorectal
cancer. Clin Microbiol Infect. 12:782–786. 2006. View Article : Google Scholar : PubMed/NCBI
|
